W hen hepatitis C was first discovered in 1989, the virus was spread largely through blood transfusions, before the blood supply was regularly screened for the virus. Now, though, hepatitis C is ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. A nurse told him he had only six months to live. He was prescribed a drug cocktail, a ...

CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient ...

Given that HCV is a bloodborne virus, any circumstance that promotes continued drug injection—including failure to prevent or diagnose and adequately treat substance use disorders—can result in ...

Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

P eople who inject drugs are the fastest-growing group at risk for hepatitis C. And yet, after receiving a diagnosis, many struggle to find sympathetic care and support, from both healthcare providers ...

(Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very ...

TRENTON, N.J. -- Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The ...

State prison systems say they can’t afford to cure everyone with hepatitis C. The drug, even after a dramatic price drop, is still expensive. But several states have recently figured out how to make ...